Coherus Oncology, Inc. - 8-K Filing
Coherus Oncology held its 2026 Annual Meeting of Stockholders on May 27, 2026 and adjourned voting for Proposal 4 until May 29. Shareholders elected directors Dennis M. Lanfear (82,524,713 votes) and Mats L. Wahlström (81,177,717), ratified Ernst & Young LLP as auditors with 121,137,511 votes in favor, approved executive compensation with 73,322,772 votes for the Say-on-Pay resolution, and voted to reduce option exercise prices (45,996,610 votes) and increase shares under its equity plan (59,507,788). (Items: 5.07 Submission of Matters to a Vote of Security Holders)
Tickers: $CHRS